安邦制药 (874011.OC)

+ 收藏

利润表(安邦制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 102,375,946.21326,005,469.99188,840,081.29317,792,952.09134,571,852.23
 营业收入(元) 102,375,946.21326,005,469.99188,840,081.29317,792,952.09134,571,852.23
二、营业总成本(元) 104,877,622.79290,950,892.34158,038,465.51293,435,300.08127,104,565.16
 营业成本(元) 65,914,177.70192,910,673.80103,455,310.95186,879,399.0284,084,669.65
 研发费用(元) 3,607,131.208,814,894.804,540,063.1315,623,584.892,809,835.63
 营业税金及附加(元) 675,978.902,093,105.181,236,850.372,399,341.301,055,865.97
 销售费用(元) 21,643,327.7357,172,682.5533,485,730.1559,442,632.2427,036,763.78
 管理费用(元) 14,891,769.2230,933,455.8116,111,909.2230,120,348.9212,749,469.40
 财务费用(元) -1,854,761.96-973,919.80-791,398.31-1,030,006.29-632,039.27
  其中:利息费用(元) 16,943.59130,073.9846,943.77162,323.5676,923.32
  其中:利息收入(元) 1,947,948.431,312,048.74933,902.631,397,191.10803,931.55
三、其他经营收益
 加:投资收益(元) 58,705.88251,462.20---
 资产处置收益(元) 11,326.80127,447.16-3,370.92-16,238.89220.30
 资产减值损失(元) -6,696,494.02-5,078,646.11-1,404,178.36-797,014.13-1,394,257.20
 信用减值损失(元) 268,416.14-579,829.95-39,018.87-287,408.05-251,227.88
 其他收益(元) 10,740,894.7315,242,810.387,546,155.6015,150,420.246,440,472.46
四、营业利润(元) 1,881,172.9545,017,821.3336,901,203.2338,407,411.1812,262,494.75
 加:营业外收入(元) 189,901.16314,576.42172,663.08212,535.5956,122.01
 减:营业外支出(元) 37,833.54342,320.2399,109.72494,699.39232,117.78
五、利润总额(元) 2,033,240.5744,990,077.5236,974,756.5938,125,247.3812,086,498.98
 减:所得税费用(元) -299,275.775,425,294.694,974,955.562,798,216.18826,150.83
六、净利润(元) 2,332,516.3439,564,782.8331,999,801.0335,327,031.2011,260,348.15
(一)按经营持续性分类
  持续经营净利润(元) 2,332,516.3439,564,782.8331,999,801.0335,327,031.2011,260,348.15
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 2,469,041.0538,407,887.2230,432,496.4733,551,825.3010,569,897.89
  少数股东损益(元) -136,524.711,156,895.611,567,304.561,775,205.90690,450.26
 扣除非经常性损益后的净利润(元) -2,024,669.3333,762,219.2627,831,566.2730,082,726.0510,414,500.00
七、每股收益
 一、基本每股收益(元) 0.040.640.510.560.18
 二、稀释每股收益(元) 0.040.640.510.560.18
九、综合收益总额(元) 2,332,516.3439,564,782.8331,999,801.0335,327,031.2011,260,348.15
 归属于母公司所有者的综合收益总额(元) 2,469,041.0538,407,887.2230,432,496.4733,551,825.3010,569,897.89
 归属于少数股东的综合收益总额(元) -136,524.711,156,895.611,567,304.561,775,205.90690,450.26
公告日期 2024-08-292024-04-262023-08-282023-03-242022-12-01
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院